JP2005537054A5 - - Google Patents

Download PDF

Info

Publication number
JP2005537054A5
JP2005537054A5 JP2004531512A JP2004531512A JP2005537054A5 JP 2005537054 A5 JP2005537054 A5 JP 2005537054A5 JP 2004531512 A JP2004531512 A JP 2004531512A JP 2004531512 A JP2004531512 A JP 2004531512A JP 2005537054 A5 JP2005537054 A5 JP 2005537054A5
Authority
JP
Japan
Prior art keywords
use according
substance
microneedle
microneedles
improved pharmacokinetics
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2004531512A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005537054A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/026750 external-priority patent/WO2004020014A2/en
Publication of JP2005537054A publication Critical patent/JP2005537054A/ja
Publication of JP2005537054A5 publication Critical patent/JP2005537054A5/ja
Withdrawn legal-status Critical Current

Links

JP2004531512A 2002-08-30 2003-08-28 免疫調節化合物の薬物動態を制御する方法 Withdrawn JP2005537054A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40691602P 2002-08-30 2002-08-30
PCT/US2003/026750 WO2004020014A2 (en) 2002-08-30 2003-08-28 Method of controlling pharmacokinetics of immunomodulatory compounds

Publications (2)

Publication Number Publication Date
JP2005537054A JP2005537054A (ja) 2005-12-08
JP2005537054A5 true JP2005537054A5 (https=) 2006-10-12

Family

ID=31978384

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004531512A Withdrawn JP2005537054A (ja) 2002-08-30 2003-08-28 免疫調節化合物の薬物動態を制御する方法

Country Status (9)

Country Link
US (2) US20040082934A1 (https=)
EP (1) EP1539241A2 (https=)
JP (1) JP2005537054A (https=)
AU (1) AU2003262888A1 (https=)
BR (1) BR0313890A (https=)
CA (1) CA2497086A1 (https=)
MX (1) MXPA05002270A (https=)
WO (1) WO2004020014A2 (https=)
ZA (1) ZA200501829B (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8465468B1 (en) 2000-06-29 2013-06-18 Becton, Dickinson And Company Intradermal delivery of substances
US20020156453A1 (en) * 1999-10-14 2002-10-24 Pettis Ronald J. Method and device for reducing therapeutic dosage
US20020095134A1 (en) * 1999-10-14 2002-07-18 Pettis Ronald J. Method for altering drug pharmacokinetics based on medical delivery platform
US20040175360A1 (en) * 2000-06-29 2004-09-09 Pettis Ronald J. Method for altering drug pharmacokinetics based on medical delivery platform
CA2444391A1 (en) * 2001-04-13 2002-10-24 Becton Dickinson And Company Methods and devices for administration of substances into the intradermal layer of skin for systemic absorption
CN1253220C (zh) * 2001-06-29 2006-04-26 贝克顿迪肯森公司 通过微管在真皮内输入疫苗和基因治疗剂
US20060018877A1 (en) * 2001-06-29 2006-01-26 Mikszta John A Intradermal delivery of vacccines and therapeutic agents
DE60328039D1 (de) * 2002-10-11 2009-07-30 Becton Dickinson Co Insulinabgabesystem mit Sensor
WO2005091922A2 (en) * 2004-03-03 2005-10-06 Becton, Dickinson And Company Methods and devices for improving delivery of a substance to skin
US8554317B2 (en) * 2005-11-30 2013-10-08 3M Innovative Properties Company Microneedle arrays and methods of use thereof
AU2012236099A1 (en) 2011-03-31 2013-10-03 Moderna Therapeutics, Inc. Delivery and formulation of engineered nucleic acids
CA3018046A1 (en) 2011-12-16 2013-06-20 Moderna Therapeutics, Inc. Modified nucleoside, nucleotide, and nucleic acid compositions
PL2922554T3 (pl) 2012-11-26 2022-06-20 Modernatx, Inc. Na zmodyfikowany na końcach
AU2013374345A1 (en) 2013-01-17 2015-08-06 Moderna Therapeutics, Inc. Signal-sensor polynucleotides for the alteration of cellular phenotypes
EP2968391A1 (en) 2013-03-13 2016-01-20 Moderna Therapeutics, Inc. Long-lived polynucleotide molecules

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3688764A (en) * 1970-08-20 1972-09-05 Bard Hamilton Co Inc Intracutaneous injection system
US3964482A (en) * 1971-05-17 1976-06-22 Alza Corporation Drug delivery device
BE795384A (fr) * 1972-02-14 1973-08-13 Ici Ltd Pansements
US4270537A (en) * 1979-11-19 1981-06-02 Romaine Richard A Automatic hypodermic syringe
IE53703B1 (en) * 1982-12-13 1989-01-18 Elan Corp Plc Drug delivery device
CA1283827C (en) * 1986-12-18 1991-05-07 Giorgio Cirelli Appliance for injection of liquid formulations
US6056716A (en) * 1987-06-08 2000-05-02 D'antonio Consultants International Inc. Hypodermic fluid dispenser
AU614092B2 (en) * 1987-09-11 1991-08-22 Paul Max Grinwald Improved method and apparatus for enhanced drug permeation of skin
EP0429842B1 (en) * 1989-10-27 1996-08-28 Korea Research Institute Of Chemical Technology Device for the transdermal administration of protein or peptide drug
US5098389A (en) * 1990-06-28 1992-03-24 Becton, Dickinson And Company Hypodermic needle assembly
US5279544A (en) * 1990-12-13 1994-01-18 Sil Medics Ltd. Transdermal or interdermal drug delivery devices
US5156591A (en) * 1990-12-13 1992-10-20 S. I. Scientific Innovations Ltd. Skin electrode construction and transdermal drug delivery device utilizing same
TW279133B (https=) * 1990-12-13 1996-06-21 Elan Med Tech
US5527288A (en) * 1990-12-13 1996-06-18 Elan Medical Technologies Limited Intradermal drug delivery device and method for intradermal delivery of drugs
SE9102652D0 (sv) * 1991-09-13 1991-09-13 Kabi Pharmacia Ab Injection needle arrangement
US5279552A (en) * 1993-01-11 1994-01-18 Anton Magnet Intradermal injection device
CA2132277C (en) * 1993-10-22 2005-05-10 Giorgio Cirelli Injection device
US5997501A (en) * 1993-11-18 1999-12-07 Elan Corporation, Plc Intradermal drug delivery device
US5591139A (en) * 1994-06-06 1997-01-07 The Regents Of The University Of California IC-processed microneedles
US5582591A (en) * 1994-09-02 1996-12-10 Delab Delivery of solid drug compositions
IE72524B1 (en) * 1994-11-04 1997-04-23 Elan Med Tech Analyte-controlled liquid delivery device and analyte monitor
WO1996037155A1 (en) * 1995-05-22 1996-11-28 Silicon Microdevices, Inc. Micromechanical device and method for enhancing delivery of compounds through the skin
US5801057A (en) * 1996-03-22 1998-09-01 Smart; Wilson H. Microsampling device and method of construction
KR20000016528A (ko) * 1996-06-10 2000-03-25 리안 안네 체액을 피하에 투여하기 위한 주사 바늘
US5871158A (en) * 1997-01-27 1999-02-16 The University Of Utah Research Foundation Methods for preparing devices having metallic hollow microchannels on planar substrate surfaces
US5928207A (en) * 1997-06-30 1999-07-27 The Regents Of The University Of California Microneedle with isotropically etched tip, and method of fabricating such a device
US6007821A (en) * 1997-10-16 1999-12-28 Fordham University Method and compositions for the treatment of autoimmune disease using heat shock proteins
IE970782A1 (en) * 1997-10-22 1999-05-05 Elan Corp An improved automatic syringe
US6482176B1 (en) * 1997-11-27 2002-11-19 Disetronic Licensing Ag Method and device for controlling the introduction depth of an injection needle
IT1298087B1 (it) * 1998-01-08 1999-12-20 Fiderm S R L Dispositivo per il controllo della profondita' di penetrazione di un ago, in particolare applicabile ad una siringa per iniezioni
US5957895A (en) * 1998-02-20 1999-09-28 Becton Dickinson And Company Low-profile automatic injection device with self-emptying reservoir
US6503231B1 (en) * 1998-06-10 2003-01-07 Georgia Tech Research Corporation Microneedle device for transport of molecules across tissue
DE19934433A1 (de) * 1999-07-22 2001-01-25 Merck Patent Gmbh N-(Indolcarbonyl-)piperazinderivate
US6319224B1 (en) * 1999-08-20 2001-11-20 Bioject Medical Technologies Inc. Intradermal injection system for injecting DNA-based injectables into humans
US6623457B1 (en) * 1999-09-22 2003-09-23 Becton, Dickinson And Company Method and apparatus for the transdermal administration of a substance
US8465468B1 (en) * 2000-06-29 2013-06-18 Becton, Dickinson And Company Intradermal delivery of substances
US20020156453A1 (en) * 1999-10-14 2002-10-24 Pettis Ronald J. Method and device for reducing therapeutic dosage
US20020095134A1 (en) * 1999-10-14 2002-07-18 Pettis Ronald J. Method for altering drug pharmacokinetics based on medical delivery platform
US6565532B1 (en) * 2000-07-12 2003-05-20 The Procter & Gamble Company Microneedle apparatus used for marking skin and for dispensing semi-permanent subcutaneous makeup
US6537242B1 (en) * 2000-06-06 2003-03-25 Becton, Dickinson And Company Method and apparatus for enhancing penetration of a member for the intradermal sampling or administration of a substance
US6607513B1 (en) * 2000-06-08 2003-08-19 Becton, Dickinson And Company Device for withdrawing or administering a substance and method of manufacturing a device
US20040175360A1 (en) * 2000-06-29 2004-09-09 Pettis Ronald J. Method for altering drug pharmacokinetics based on medical delivery platform
US20050008683A1 (en) * 2000-06-29 2005-01-13 Becton Dickinson And Company Method for delivering interferons to the intradermal compartment
US20030073609A1 (en) * 2001-06-29 2003-04-17 Pinkerton Thomas C. Enhanced pharmacokinetic profile of intradermally delivered substances
US7429258B2 (en) * 2001-10-26 2008-09-30 Massachusetts Institute Of Technology Microneedle transport device
AU2002348829A1 (en) * 2001-12-21 2003-07-09 Dr. Reddy's Laboratories Ltd. Novel compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them
US20050096332A1 (en) * 2003-10-30 2005-05-05 Boehringer Ingelheim International Gmbh Use of tyrosine kinase inhibitors for the treatment of inflammatory processes
WO2005091922A2 (en) * 2004-03-03 2005-10-06 Becton, Dickinson And Company Methods and devices for improving delivery of a substance to skin

Similar Documents

Publication Publication Date Title
JP2005537054A5 (https=)
US9192750B2 (en) Method and device for controlling drug pharmacokinetics
JP2005503359A5 (https=)
Margetts et al. Transdermal drug delivery: principles and opioid therapy
Priya et al. Transdermal iontophoresis
KR101830398B1 (ko) 무고통 및 무패치의 슈팅 마이크로구조체
ES2292601T3 (es) Administracion de sustancias en la dermis.
RU2719943C2 (ru) Способы улучшенной доставки активных средств в опухоли
JP2004537540A (ja) 真皮内送達物質の全身吸収増大
RU2719946C2 (ru) Способы доставки активных средств в лимфатическую систему
JP2004537540A5 (https=)
ATE410153T1 (de) Transdermales verabreichungssystem mit individueller dosierung
WO2006031856A2 (en) Biosynchronous transdermal drug delivery
KR20180056411A (ko) 복합 제형이 적용된 마이크로니들 어레이 및 이의 제조방법
CN1638826A (zh) 减少治疗剂量的方法和装置
MXPA03009371A (es) Metodos y dispositivos para administrar sustancias en la capa intradermica de la piel para absorcion sistemica.
Giannola et al. Physical methods to promote drug delivery on mucosal tissues of the oral cavity
KR20140105397A (ko) 음압을 이용한 마이크로구조체의 제조방법 및 그로부터 제조된 마이크로구조체
CA2497086A1 (en) Method of controlling pharmacokinetics of immunomodulatory compounds
JP2021505267A (ja) 高密度マイクロニードル
Ramezanli et al. Transdermal delivery of drugs using patches and patchless delivery systems
Ramana et al. TRANSDERMAL DRUG DELIVERY SYSTEM IN ADVANCED TECHNOLOGY
HK1074590A (en) Enhanced systemic absorption of intradermally delivered substance
RU2006137657A (ru) Применение производных камптотецина для лечения пролиферативных заболеваний с использованием схемы лечения с фиксированной дозой
KR20130024202A (ko) 점층적 약물투여와 투여 시간 간격이 조절가능한 의료용 패치.